The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of disease.
本发明涉及化合物和方法,用于作为磷酸二酯酶4(PDE4)的抑制剂,用于治疗或预防疾病。
Heteroaryl inhibitors of PDE4
申请人:Tetra Discovery Partners, LLC
公开号:US10093686B2
公开(公告)日:2018-10-09
The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.